Though this does not appear to play a role in the maintenance of cetuximab resistance, since knockdown of IL6, IL6R, and IL6ST did not sensitize the cells to cetuximab, the respective contributions of intracellular and extracellular IL-6 in HNSCC may be a topic of further study. The gene discussed is IL6; the disease is head and neck squamous cell carcinoma.